JRCT ID: jRCT2080224631
Registered date:10/04/2019
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 22/04/2019 |
Target sample size | 30 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 391 Agents for liver disease Dosage and Administration for Investigational material : Single dose control material(s) Generic name etc : Placebo INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : Single dose |
Outcome(s)
Primary Outcome | pharmacokinetics |
---|---|
Secondary Outcome | safety other |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 44age old |
Gender | Male |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | EA Pharma Co., Ltd. |
---|---|
Secondary Sponsor | - |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT03922633,JapicCTI-194703 |
Contact
Public contact | |
Name | |
Address | |
Telephone | |
contact_ea@eapharma.co.jp | |
Affiliation | EA Pharma Co., Ltd. |
Scientific contact | |
Name | |
Address | |
Telephone | |
contact_ea@eapharma.co.jp | |
Affiliation | EA Pharma Co., Ltd. |